MedPath

山东绅联药业股份有限公司

Ownership
-
Established
2015-08-25
Employees
-
Market Cap
-
Website
http://www.sheelian.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Cyclopentolate Hydrochloride Eye Drops

Product Name
盐酸环喷托酯滴眼液
Approval Number
国药准字H20253278
Approval Date
Jan 24, 2025
NMPA

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20253182
Approval Date
Jan 14, 2025
NMPA

Cyclopentolate Hydrochloride Eye Drops

Product Name
盐酸环喷托酯滴眼液
Approval Number
国药准字H20249236
Approval Date
Oct 29, 2024
NMPA

Heparin Sodium

Product Name
肝素钠
Approval Number
国药准字H20163292
Approval Date
Aug 25, 2016
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.